NCT05170828 2026-02-24Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesOssium Health, Inc.Phase 1 Withdrawn
NCT05589896 2026-02-24A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.Phase 1/2 Recruiting12 enrolled
NCT03112603 2025-08-12A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)Incyte CorporationPhase 3 Completed330 enrolled 32 charts 2 FDA